{
    "title": "Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12343555/Japans-Takeda-beats-Q1-profit-estimates-mainstay-drugs-dengue-vaccine.html",
    "date": "2023-07-27",
    "keywords": [
        "year",
        "profit",
        "drug",
        "company",
        "dengue",
        "pipeline",
        "operating",
        "forecast",
        "december",
        "vaccine",
        "tokyo",
        "july",
        "mainstay",
        "launch",
        "fever",
        "result",
        "start",
        "takeda",
        "patent",
        "protection",
        "june",
        "drugmaker",
        "average",
        "exclusivity",
        "blood",
        "pressure",
        "azilva",
        "japan",
        "hyperactivity",
        "vyvanse",
        "psoriasis",
        "nimbus",
        "purchase",
        "takeover",
        "shire",
        "plc",
        "qdenga",
        "win",
        "companys",
        "inhouse",
        "application",
        "approval",
        "month",
        "collection",
        "thursday",
        "end",
        "surge",
        "benchmark",
        "swift",
        "hogue",
        "robert",
        "birsel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}